Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177717 · ClinicalTrials.gov registry record
Deep Functional Phenotyping of the ALA Lung Health Cohort
A clinical trial of Lung Diseases, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 12
- Study locations
NCT06177717: Recruiting study of Lung Diseases, sponsored by Johns Hopkins University.
NCT06177717 is a study of Lung Diseases that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,000 participants, above the 707-participant average among 31 other Lung Diseases trials with a reported enrollment target (41% higher). The trial reports 12 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06177717, a study of Lung Diseases, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' airways, * the structure of blood vessels in the participants lungs and heart, and * the participants lungs' ability to exchange gases. Participants will take four different lung function tests to measure lung function, including: * air movement in the lungs (oscillometry) * lung size (slow vital capacity (SVC) and functional residual capacity (FRC) * gas transfer in the lungs (diffusing capacity for carbon monoxide (DLCO).
Primary Outcome
Correlation of adverse modifiable exposures and risk factors with increased airway-parenchymal dysanapsis
Conditions Studied
Study Locations (12)
North Carolina
- Duke University - Durham
- Wake Forest School of Medicine - Winston-Salem
Alabama
- University of Alabama - Birmingham
California
- University of California, Los Angeles - Los Angeles
Colorado
- National Jewish Health - Denver
Florida
- Nemours Children's Jacksonville - Jacksonville
Illinois
- Northwestern University - Chicago
Kansas
- University of Kansas - Kansas City
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2026-07-30 |
What NCT06177717 shows while recruiting
NCT06177717 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 707-participant average among 31 other Lung Diseases trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT06177717 lists 12 locations in 11 states (North Carolina, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT06177717 about?
NCT06177717 is a clinical study titled "Deep Functional Phenotyping of the ALA Lung Health Cohort". The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' ...
What is the current status of trial NCT06177717?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-02-12. Estimated completion is 2026-07-30.
What conditions does trial NCT06177717 study?
This clinical trial studies the following conditions: Lung Diseases.
Who is sponsoring clinical trial NCT06177717?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177717 being conducted?
This trial has 12 study locations across Alabama, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06177717's enrollment target sits among peer trials
1,000 7th of 31 higher than 25 of 31 other Lung Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
American Lung Association (ALA) Lung Health Cohort
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI